Cargando…

A Review of Repurposed Cancer Drugs in Clinical Trials for Potential Treatment of COVID-19

The pandemic of the coronavirus disease 2019 (COVID-19) represents an unprecedented challenge to identify effective drugs for prevention and treatment. While the world’s attention is focused on news of COVID-19 vaccine updates, clinical management still requires improvement. Due to the similarity of...

Descripción completa

Detalles Bibliográficos
Autores principales:	Costa, Bárbara, Vale, Nuno
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8229933/ https://www.ncbi.nlm.nih.gov/pubmed/34070725 http://dx.doi.org/10.3390/pharmaceutics13060815

Ejemplares similares

In Vitro Drug Repurposing: Focus on Vasodilators
por: Ribeiro, Eduarda, et al.
Publicado: (2023)

Pharmacological Efficacy of Repurposing Drugs in the Treatment of Prostate Cancer
por: Lourenço, Tânia, et al.
Publicado: (2023)

Repurposing of the Drug Tezosentan for Cancer Therapy
por: Ribeiro, Eduarda, et al.
Publicado: (2023)

Repurposed Drugs in Gastric Cancer
por: Araújo, Diana, et al.
Publicado: (2022)

Drug Repurposing in Cancer Therapy: Influence of Patient’s Genetic Background in Breast Cancer Treatment
por: Rodrigues, Rafaela, et al.
Publicado: (2022)

The Role of Dopamine in Repurposing Drugs for Oncology
por: Moura, Catarina, et al.
Publicado: (2023)

Drug Repurposing for Schistosomiasis: Combinations of Drugs or Biomolecules
por: Gouveia, Maria João, et al.
Publicado: (2018)

An Overview of Repurposed Drugs for Potential COVID-19 Treatment
por: Govender, Kamini, et al.
Publicado: (2022)

Drug combination and repurposing for cancer therapy: the example of breast cancer
por: Correia, Ana Salomé, et al.
Publicado: (2021)

Drug repurposing for the treatment of COVID-19
por: Kato, Yuri, et al.
Publicado: (2022)

Repurposing Anti-Cancer Drugs for COVID-19 Treatment
por: Borcherding, Nicholas, et al.
Publicado: (2020)

Drug Metabolism for the Identification of Clinical Biomarkers in Breast Cancer
por: Costa, Bárbara, et al.
Publicado: (2022)

Drug Repurposing Approach, Potential Drugs, and Novel Drug Targets for COVID-19 Treatment
por: Kifle, Zemene Demelash, et al.
Publicado: (2021)

Potential Drug Interactions of Repurposed COVID-19 Drugs with Lung Cancer Pharmacotherapies
por: Baburaj, Gayathri, et al.
Publicado: (2021)

Repurposing Existing Drugs for the Treatment of COVID-19
por: Farne, Hugo, et al.
Publicado: (2020)

Brief review on repurposed drugs and vaccines for possible treatment of COVID-19
por: De, Priyasha, et al.
Publicado: (2021)

COVID-19 and pulmonary fibrosis: therapeutics in clinical trials, repurposing, and potential development
por: Yim, Joowon, et al.
Publicado: (2021)

Towards Drug Repurposing in Cancer Cachexia: Potential Targets and Candidates
por: Santos, Joana M. O., et al.
Publicado: (2021)

Drug Repurposing for Prevention and Treatment of COVID-19: A Clinical Landscape
por: Hossain, Md. Shahadat, et al.
Publicado: (2020)

Clinical trial protocols of repurposed prophylaxis for COVID-19: A review
por: Sallard, E., et al.
Publicado: (2021)

Potential treatments of COVID-19: Drug repurposing and therapeutic interventions
por: Raghav, Pawan Kumar, et al.
Publicado: (2023)

Repurposing drugs for treatment of COVID-19
por: Venkatesan, Priya
Publicado: (2021)

Repurposed pharmacological agents for the potential treatment of COVID-19: a literature review
por: Kröker, Alina, et al.
Publicado: (2021)

A Clinical Insight on New Discovered Molecules and Repurposed Drugs for the Treatment of COVID-19
por: Banerjee, Surojit, et al.
Publicado: (2023)

Computational drug discovery and repurposing for the treatment of COVID-19: A systematic review
por: Mohamed, Kawthar, et al.
Publicado: (2021)

Exploring Repurposing Potential of Existing Drugs in the Management of COVID-19 Epidemic: A Critical Review
por: Chakraborty, Debjit, et al.
Publicado: (2020)

Rapamycin as a potential repurpose drug candidate for the treatment of COVID-19
por: Husain, Amjad, et al.
Publicado: (2020)

Impact of Liver Functions by Repurposed Drugs for COVID-19 Treatment
por: Zhang, Rongzhi, et al.
Publicado: (2022)

Repurposing anticancer drugs for the management of COVID-19
por: El Bairi, Khalid, et al.
Publicado: (2020)

Drug repurposing approach to fight COVID-19
por: Singh, Thakur Uttam, et al.
Publicado: (2020)

Artificial intelligence in COVID-19 drug repurposing
por: Zhou, Yadi, et al.
Publicado: (2020)

Progress, pitfalls, and path forward of drug repurposing for COVID-19 treatment
por: Taibe, Noha Samir, et al.
Publicado: (2022)

Repurposed GI Drugs in the Treatment of COVID-19
por: Aguila, Enrik John T., et al.
Publicado: (2020)

Ivermectin: Potential Role as Repurposed Drug for COVID-19
por: Dixit, Alok, et al.
Publicado: (2020)

Psychotropic drug repurposing for COVID-19: a systematic review
por: Isayeva, U., et al.
Publicado: (2022)

Prospects for repurposing CNS drugs for cancer treatment
por: Abdelaleem, Mohamed, et al.
Publicado: (2019)

The Potential for Repurposing Anti-TNF as a Therapy for the Treatment of COVID-19
por: Robinson, Philip C., et al.
Publicado: (2020)

Repurposing Potential of the Antiparasitic Agent Ivermectin for the Treatment and/or Prophylaxis of COVID-19
por: Awad, Hoda, et al.
Publicado: (2022)

A review on drug repurposing in COVID-19: from antiviral drugs to herbal alternatives
por: Sezer, Abas, et al.
Publicado: (2022)

Personalized Medicine for Classical Anesthesia Drugs and Cancer Progression
por: Costa, Bárbara, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_0b2r7553f4paul4rd7dl2pp0gv